{"name":"AnGes USA, Inc.","slug":"anges-usa-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"AMG0001","genericName":"AMG0001","slug":"amg0001","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"AMG0001","genericName":"AMG0001","slug":"amg0001","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNTFMzUENuNFFsYjNnZk43QnpsMFd3X2lQdVBidUxQV1R4SkNtMXhickNRWnBlcXdYY0llLWJudHVGenp2c0xCejJwZXJDUWVsRmlTMTZfdUtOWUdGRVpqWkpUeUdaaVpoSmZZOV9iUUdjWXd3RWloSUdlMzZtcnlXNGlvSFJvLUF0VGRIVFM1ZXU0X1QwblBtVA?oc=5","date":"2025-08-21","type":"pipeline","source":"Pharmaceutical Technology","summary":"Boehringer and AnGes link on drug substance manufacture for PAD - Pharmaceutical Technology","headline":"Boehringer and AnGes link on drug substance manufacture for PAD","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxPNnFYZDl6cVNBNGJGSlpGZDYxaTdnYlhZQlJxSEIxWHdIbHNVSkx6a1lfVHhiM0xKcXJQVzhFVFBISzdSeWVjWkk3aUpudEV6MXFvTS1KQlhldVNfem1YeXFObTQ0REZHajNwdzhVMGthYzV0SHFNSzRnd05mR3BPYXpwRUIwRDFZZ2FqQ2IwRDV0WnN1VDlnQTFHTV9YWWxBQ0NKb0tKQk51bXctNW9NNHh5STc0VE5XbWNvWWM0SlBtbG9UbXljSQ?oc=5","date":"2025-08-20","type":"deal","source":"European Pharmaceutical Review","summary":"Boehringer Ingelheim signs gene therapy manufacturing deal with AnGes - European Pharmaceutical Review","headline":"Boehringer Ingelheim signs gene therapy manufacturing deal with AnGes","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}